Canna-Pet® Success Moves Peak Pharmaceuticals Forward

Peak Pharmaceuticals, Inc. (OTCQB: PKPH) and Canna-Pet, a leading innovator of non-prescription hemp based cannabinoid products for animals, announced early in April that an initial trial run of their newly formulated MaxCBD Maple Bacon Biscuits sold out much faster than anticipated. Given the rapid acceptance of the product, it was no surprise that the Company acted…

The post Canna-Pet® Success Moves Peak Pharmaceuticals Forward appeared first on Marijuana Index.